Emtricitabine/Tenofovir disoproxil fumarate [clinicaltrials_resource:8b8ef44f7e4f8bf8708e41c5565a40fd]
intervention [clinicaltrials_vocabulary:intervention]
Emtricitabine/Tenofovir disoproxil fumarate [clinicaltrials_resource:8b8ef44f7e4f8bf8708e41c5565a40fd]
Bio2RDF identifier
8b8ef44f7e4f8bf8708e41c5565a40fd
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:8b8ef44f7e4f8bf8708e41c5565a40fd
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
200-mg emtricitabine and 300 m ...... ablet, taken orally once daily
intervention name [clinicaltrials_vocabulary:intervention-name]
Emtricitabine/Tenofovir disoproxil fumarate
other name [clinicaltrials_vocabulary:other-name]
identifier
clinicaltrials_resource:8b8ef44f7e4f8bf8708e41c5565a40fd
title
Emtricitabine/Tenofovir disoproxil fumarate
@en
type
label
Emtricitabine/Tenofovir disopr ...... ef44f7e4f8bf8708e41c5565a40fd]
@en